As of August 28, 2026, Ocular Therapeutix, Inc. (OCUL) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. Ocular Therapeutix, Inc. has a market capitalization of $1.97B, 219.62M shares outstanding, 272 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for OCUL.
Market Data
Market Cap$1.97B
Shares Outstanding219.62M
Float184.63M
Cash$598.64M
Debt$18.00M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 23.6% shares (2026Q1 vs prior)
272 institutional holders · 244.92M shares
#1
FMR LLC
32.65M shares
#2
Avoro Capital Advisors LLC
23.09M shares
#3
Deep Track Capital, LP
19.69M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest26.74M
Days to Cover13.5
% of Float14.5%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2024-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual OCUL Dilution Snapshot
Ocular Therapeutix, Inc. (OCUL) has a DilutionScore of 25/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for OCUL: xbrl on 2024-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track OCUL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OCUL — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for OCUL
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.